Voyager Therapeutics Inc (VYGR) Insider Trading
- $92,031,920.32
- $16,424,596.23
- Feb. 24, 2026
- Todd Alfred Carter
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Insider | 4,174 | $3.76 | Sell | $15,694.24 | |
| Feb. 24, 2026 | CEO | 14,197 | $3.79 | Sell | $53,806.63 | |
| Feb. 24, 2026 | CFO | 4,668 | $3.77 | Sell | $17,598.36 | |
| Feb. 24, 2026 | COO | 6,458 | $3.77 | Sell | $24,346.66 | |
| Feb. 10, 2026 | CEO | 12,192 | $3.78 | Sell | $46,085.76 | |
| Feb. 10, 2026 | Insider | 3,525 | $3.85 | Sell | $13,571.25 | |
| Feb. 10, 2026 | COO | 4,569 | $3.85 | Sell | $17,590.65 | |
| April 2, 2025 | CEO | 10,885 | $3.43 | Sell | $37,335.55 | |
| Jan. 14, 2025 | Insider | 1,191 | $5.13 | Sell | $6,109.83 | |
| Jan. 14, 2025 | COO | 3,087 | $5.09 | Sell | $15,712.83 | |
| Dec. 23, 2024 | COO | 6,500 | $5.65 | Sell | $36,725.00 | |
| Oct. 2, 2024 | Insider | 5,999 | $5.82 | Sell | $34,914.18 | |
| Jan. 17, 2024 | COO | 2,543 | $7.15 | Sell | $18,182.45 | |
| Jan. 17, 2024 | Insider | 1,266 | $7.18 | Sell | $9,089.88 | |
| Oct. 3, 2023 | CFO | 13,567 | $6.99 | Sell | $94,833.33 | |
| Sept. 15, 2023 | Insider | 10,500 | $8.16 | Sell | $85,680.00 | |
| July 6, 2023 | Insider | 5,500 | $10.80 | Sell | $59,400.00 | |
| April 3, 2023 | COO | 1,259 | $7.83 | Sell | $9,857.97 | |
| April 3, 2023 | CEO | 7,437 | $7.83 | Sell | $58,231.71 | |
| March 20, 2023 | Insider | 2,193 | $7.76 | Sell | $17,017.68 | |
| March 20, 2023 | COO | 3,654 | $7.76 | Sell | $28,355.04 | |
| March 20, 2023 | VP | 4,410 | $7.76 | Sell | $34,221.60 | |
| Feb. 23, 2023 | Major Shareholder | 4,395,588 | $8.88 | Buy | $39,032,821.44 | |
| Feb. 17, 2023 | Insider | 738 | $7.45 | Sell | $5,498.10 | |
| Feb. 17, 2023 | VP | 3,297 | $7.45 | Sell | $24,562.65 | |
| Feb. 13, 2023 | Insider | 797 | $7.67 | Sell | $6,112.99 | |
| Feb. 13, 2023 | VP | 2,868 | $7.67 | Sell | $21,997.56 | |
| Feb. 1, 2023 | Major Shareholder | 128,642 | $9.32 | Sell | $1,198,943.44 | |
| Jan. 30, 2023 | Major Shareholder | 75,000 | $9.03 | Sell | $677,250.00 | |
| Jan. 27, 2023 | Major Shareholder | 50,000 | $9.02 | Sell | $451,000.00 | |
| Jan. 25, 2023 | Major Shareholder | 50,000 | $9.22 | Sell | $461,000.00 | |
| Jan. 23, 2023 | Major Shareholder | 55,000 | $9.06 | Sell | $498,300.00 | |
| Jan. 20, 2023 | Major Shareholder | 100,000 | $9.15 | Sell | $915,000.00 | |
| Jan. 17, 2023 | VP | 2,188 | $9.85 | Sell | $21,551.80 | |
| Jan. 17, 2023 | Insider | 1,106 | $9.85 | Sell | $10,894.10 | |
| Jan. 11, 2023 | Major Shareholder | 110,000 | $8.50 | Sell | $935,000.00 | |
| Jan. 9, 2023 | Major Shareholder | 456,000 | $7.67 | Sell | $3,497,520.00 | |
| Aug. 24, 2022 | Major Shareholder | 149,972 | $6.09 | Sell | $913,329.48 | |
| Aug. 15, 2022 | Major Shareholder | 135,808 | $6.04 | Sell | $820,280.32 | |
| Aug. 12, 2022 | Major Shareholder | 348,007 | $6.12 | Sell | $2,129,802.84 | |
| July 14, 2022 | Director | 9,512 | $6.70 | Sell | $63,730.40 | |
| July 14, 2022 | N/A | 9,512 | $6.70 | Sell | $63,730.40 | |
| July 14, 2022 | N/A | 13,891 | $6.70 | Sell | $93,069.70 | |
| June 23, 2022 | Major Shareholder | 376,000 | $5.66 | Buy | $2,128,160.00 | |
| June 21, 2022 | Major Shareholder | 101,400 | $5.28 | Buy | $535,392.00 | |
| April 4, 2022 | VP | 2,786 | $8.25 | Sell | $22,984.50 | |
| April 4, 2022 | COO | 1,527 | $8.25 | Sell | $12,597.75 | |
| March 21, 2022 | VP | 4,955 | $8.29 | Sell | $41,076.95 | |
| March 21, 2022 | COO | 4,413 | $8.29 | Sell | $36,583.77 | |
| Feb. 11, 2022 | VP | 3,252 | $3.36 | Sell | $10,926.72 |
Insiders are both buying and selling Voyager Therapeutics Inc stock.
The insider traders at Voyager Therapeutics Inc are: Todd Alfred Carter, Bernard Ravina, Rock Ventures Iii L.P. Third, Robin Swartz, Robert W Hesslein, Alfred Sandrock, Ecor1 Capital, Llc, Jane Henderson, Glenn Pierce, Neurocrine Biosciences Inc, Andre Turenne, Julie Burek, James A Geraghty, Allison Dorval, Sandell Jacquelyn Fahey, Steven M Paul, Peter P Pfreundschuh, Matthew P Ottmer, Nathan D Jorgensen, Omar Khwaja, Higgins Michael J, PIERCE GLENN, and Dinah Ph.D. Sah
The most active insider trader at Voyager Therapeutics Inc is Todd Alfred Carter with 10 trades.
Rock Ventures Iii L.P. Third has sold the most Voyager Therapeutics Inc stock with a total value of $9,263,849.52.
Neurocrine Biosciences Inc has bought the most Voyager Therapeutics Inc stock with a total value of $128,055,189.76.
The most recent insider trade for Voyager Therapeutics Inc was on Feb. 24, 2026.
The single biggest insider buy for Voyager Therapeutics Inc was from Neurocrine Biosciences Inc with a total value of $49,989,546.88 on March 12, 2019.
The single biggest insider sell for Voyager Therapeutics Inc was from Ecor1 Capital, Llc with a total value of $3,497,520.00 on Jan. 9, 2023.
